Cooperation with patient organizations

The patient comes first

For Bayer HealthCare Pharmaceuticals, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.

Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.

Bayer HealthCare Pharmaceuticals cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.

Our principles

Cooperation between Bayer HealthCare Pharmaceuticals and patient organizations is based on the following principles.
1. In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:

  • raising awareness for certain diseases by improving diagnostic possibilities and preventive measures,
  • knowing the patients' prospects and needs,
  • understanding diseases and making sure that patients receive the best medical treatment available,
  • improving the information provided to the patients,
  • supporting medical innovations.

2. Bayer HealthCare Pharmaceuticals and the patient organizations comply with international and national laws and regulations.

3. Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.

4. Bayer HealthCare Pharmaceuticals respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.

Overview of cooperation with patient organizations in Europe in 2010

The following is a list of patient organizations with which Bayer HealthCare Pharmaceuticals and its affiliated companies in Europe cooperated in 2010.

Headquarters Europe  
Patient OrganisationNature and Purpose of SupportValue in EUR
     
Alliance Chronischer Seltener Erkrankungen e.V. Financial Support Admission Fee Opening Event ACHSE e.V. 2.500
Alzheimer Europe Financial Support Value of Knowing Project 310.000
Anticoagulation Europe Cooperation Agreement Action for Stroke Prevention Alliance 1.000
European Federation of Neurological Associations Sponsoring Educational Programme HTA Summer School 25.000
European Haemophilia Consortium Financial Support 22.000
European Organisation for Rare Diseases Financial Support ECRD 2010 Krakow Conference Report 5.000
International Federation for Spina Bifida and Hydrocephalus
Sponsoring European Disease Awareness Raising Events
Financial Support Speaker Contribution Medical Affairs Meeting
Financial Support Unrestricted Grant to Raise Awareness
Financial Support Creation and Presentation of NTD Report

60.000

1.000

60.000

358.340

Israel Pulmonary Hypertension Association Sponsoring & Financial Support Pulmonary Hypertension Roundtable/AdBoard 3.000
Pro Retina Deutschland e.V. Financial Support Euro Tandem Germany Tour 5.000
Pulmonary Hypertension Association Europe
Financial Support European Leaders Meeting at the ERS 2010
Sponsoring & Financial Support Pulmonary Hypertension Roundtable/AdBoard
Financial Support Attendance of Ventavis Nurse Workshop
Sponsoring PH Initiative in Wiener Kunst-Adventskalender

30.000

1.500

257

8.000

Pulmonare Hypertonie e.V. Sponsoring Pulmonary Hypertension Awareness Days 5.000
Country More Information 
Austria Country website  
Baltic States Reports can be received from UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania)
Alina Tikuišienė MD
Zirmunu str. 68A
LT-09124 Vilnius/Lithunia
Belgium/Luxemburg Country website  
Bulgaria Country website  
Croatia Country website  
Czech Republic Country website  
Denmark Country website  
Finland Country website  
France Country website  
Germany Country website  
Greece No cooperations in 2009 Bayer Hellas AG
Kostas Roros
Sorou 18-20
15125 Marousi - Athens
Hungary Country website  
Iceland Reports can be received from Bayer AB - Bayer HealthCare Pharmaceuticals Scandinavia
Lennart Skoogh
Box 606
S-169 26 - Solna
Ireland Country website  
Italy Country website  
Netherlands Country website  
Norway Country website  
Poland Country website  
Portugal Country website  
Rumania Reports can be received from Bayer SRL Romaniu
Catalin Radu
B-dul Dimitrie Pompei 9-9A
IRIDE Business Center
Building 20, 4th Floor
020335 Bucharest, Sector 2
Serbia Reports can be received from Bayer Pharma d.o.o.
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade
Slovenia Reports can be received from Bayer d.o.o.
Lucija Zlodi Gosnik
Bravničarjeva 13
1000 Ljubljana
Slovakia Country website  
Spain Country website  
Sweden Country website  
Switzerland Country website  
Turkey Country website  
UK Country website  

Joint efforts

Click here for more information about our commitment.

Information for Download

Page tools
.
IFPMA Partnerships Book
EFPIA ─ Medicines for Mankind

open
close
http://www.bayerpharma.com/en/corporate-responsibility/access-to-medicines/joint-efforts/patient-organizations/index.php

Copyright © Bayer Pharma AG